Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088621
Status:
COMPLETED
Last Update Posted:
2014-04-17
First Post:
2004-07-30
Brief Title:
A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia
Sponsor:
Sumitomo Pharma America Inc
Organization:
Sumitomo Pharma America Inc
Organization Data
Organization:
Sumitomo Pharma America Inc
Class:
INDUSTRY
Study ID:
D1050199
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sumitomo Pharma America Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None